Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship

Ministério da Saúde. Instituto Nacional de Saúde. Maputo, Moçambique./ Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Epicentre. Paris, France.
Ministério da Saúde. Instituto Nacional de Saúde. Maputo, Moçambique.
Epicentre. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France./ University Paris Sud. Faculty of Pharmacy. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Epicentre. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France.

Resumen en ingles

We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial.

Palabras clave en ingles

TB/HIV coinfection
Nevirapine
Efavirenz
Drug–drug interactions

Referencia

BHATT, N. B. et al. Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship. Journal of Antimicrobial Chemotherapy, v. 70, n. 1, p. 225-232, 2015.

DOI

10.1093/jac/dku348

ISSN

0305-7453

Por favor, use este identificador para citar o enlazar este ítem: https://www.arca.fiocruz.br/handle/icict/29597

Tipo

Derechos de autor

Acceso restringido

Fecha del embargo

2028-08-30

Colecciones

Compartir

Estadísticas

Metadatos

Autor

Afiliación

Resumen en ingles

Palabras clave en ingles

Referencia

DOI

ISSN